http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-9904024-A2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
filingDate 1996-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6921d009f04cb472144c54eb7773cb35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87a68a1fdd97b8f7aba0adf15d6b9bcd
publicationDate 2000-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-9904024-A2
titleOfInvention Oral dosage forms containing a proton pump inhibitor and an antacid or alginate
abstract The present invention is directed to novel drug delivery masts comprising one acid multiplexing agent and one or more acid blocking agents and / or alginates, for use in the treatment and prophylaxis of dyspepsia symptoms, and to formulators for the preparation process. The unit doses are contained in at least two pharmacologically active limbs in the drug delivery core and are coated with at least the cough suppressor inhibitors. According to the present invention, the novel shootmill is produced by: a) forming a pellet with a bladder suppressor inhibitor, which is compressed into tablets with tableting excipients, and then with a layer of suction agent (s) added to this core, with a layer of segregated layer, or a layer surrounding the core. or the pellet is mixed with excipients and one or more acid impurities to be primed or tableted; or b) mixing the bladder suppressor with excipients, compressing them into tablets, which is applied by applying a separating layer to the enteric and intestinal tract in an enteric coating agent (s) or alginate with excipients. ŕ
priorityDate 1996-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87060060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450426460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10154242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10219492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454570538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451697868
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452983744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420254293
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448677000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449846142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450553376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453694953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449486356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450718528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID170206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21906954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448969875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9568613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56842000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451932064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9579578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732907

Total number of triples: 80.